and July 2010. Serious adverse events occurred in 1.5% of biopsies. The complication rate was not different between nephrology units. The mean number of glomeruli on biopsy was 14.2 8 8.6 with LM and 4.4 8 3.3 on IF. It was different according to the nephrology unit for LM (p = 0.01) and for IF (p ! 0.001). The number of failed biopsies was influenced by the nephrology unit and radiological guidance technique, favoring real-time US guidance. Failed biopsies using US or tomodensitometry assessment before RB was certainly due to kidney imprecise localization since it was often non-renal tissue sampling. At least 10 glomeruli were found in 69% of biopsies on LM. This rate varied according to the nephrology unit (p = 0.004) and was higher when 14-gauge needles were used in comparison with 16-gauge needles. Conclusion: RB is safe regardless of the technical procedure, but radiological guidance and needle size influence the efficiency of biopsies.
Introduction
Renal biopsy (RB) is necessary for the diagnosis, prognostic assessment, and therapy guidance of various diseases affecting native kidneys or transplants. Percutaneous native kidney RB procedures vary widely among nephrology units according to personal experience and availability of particular techniques [1] . The gold-standard procedure should maximize the yield of tissue sampled and minimize the risk of major hemorrhagic complications.
Three techniques are currently used for radiological guidance: real-time ultrasonographic (US) guidance, US assessment before RB, and tomodensitometry. These procedures are respectively used in 67, 26, and 6% of the French nephrology units [1] . Biopsy-core needle size varies from 12-to 18-gauge; 16-gauge is the most used (58.3% of French nephrologists) [1] .
As an invasive procedure, RB incurs potential bleeding complications of variable severity from transitory gross hematuria or pauci symptomatic hematoma to massive bleeding requiring nephrectomy and, very rarely, death [2] [3] [4] . Although several studies have revealed risk factors associated with bleeding [5] [6] [7] , it remains unknown which procedure best prevents complications. Procedures might influence renal core size, which is critical for diagnosis. Clearly, having many tissues and glomeruli is diagnostically useful [8] . To our knowledge, few studies have been published on the efficiency of RB procedures in adults and the gold standard for RB procedures remains to be defined [9] [10] [11] .
Our study compares the safety and efficiency of five native kidney percutaneous biopsy procedures in five nephrology units.
Subjects and Methods

Patients
Data from percutaneous native kidney biopsies performed between January 2006 and July 2010 in five nephrology units in the south of France were retrospectively collected. We recorded age at biopsy, gender, number of glomeruli on light microscopy (LM), number of glomeruli on immunofluorescence (IF), histopathological diagnosis, and the occurrence of any serious adverse event following RB. A serious adverse event was defined as bleeding requiring transfusion (hematoma or hematuria), arteriovenous fistula requiring embolization, pneumoperitoneum or urinoma, nephrectomy for bleeding or death.
Renal Biopsy Procedures
The five nephrology units, C1-C5, consisted of one teaching hospital (C1), two public general hospitals, and two private centers. The RB procedures of these units are reported in table 1 . All the units gave the patients oral and written information on the procedure and risks of the RB. Only one of the five units did not require written consent.
In C1, oral and written information and consent was collected. Assessment of hemorrhagic risk factors before RB consisted of oral questioning about personal bleeding history, blood cell count, coagulation tests, and bleeding time. Nephrologists did not perform biopsy if systolic blood pressure was 1 150 mm Hg or if diastolic blood pressure was 1 90 mm Hg. No sterile urinalysis was required. The biopsy was performed by a senior or junior nephrologist. Overall, 4 different persons performed RB of this study. Nephrology fellows always performed under senior supervising. Radiological guidance was performed with US assessment before RB. Two biopsy cores were taken with a 14-gauge core-cutting needle automated side-notch biopsy gun. Patients were monitored during 24 h in hospital lying in bed.
In C2, assessment of hemorrhagic risk factors was the same as in C1 except that blood pressure control required was less stringent, i.e. ^ 160/95 mm Hg. C2 was the only unit in which radiologists but not the nephrologists performed the kidney biopsy. In C2 as well as C3, C4 and C5, only 1 person performed all biopsies of this study. The sampling was performed with US guidance: US was performed during the biopsy. As in C1, two fragments were taken with a 14-gauge core-cutting needle automated biopsy gun and patients were monitored during 24 h lying in bed.
In C3, the same hemorrhagic risk factors were assessed except bleeding time, which was not required. Blood pressure control was ^ 140/90 mm Hg. Kidney biopsies were performed by the nephrologists with tomodensitometry guidance. Two fragments were taken with a 14-gauge needle automated biopsy gun. Patients were monitored 24 h in hospital after biopsy as in all other units.
In C4, nephrologists performed biopsy with US guidance like the radiologist in C2. The automatic biopsy gun needle was 16-gauge, which is smaller than in C1, C2, and C3. Two fragments were systematically taken: one for LM and one for IF. Only coagulation tests and oral bleeding history were checked but not blood cell count, urinalysis, or bleeding time. Blood pressure was required to be ^ 140/90 mm Hg before biopsy and patients stayed in bed for 24 h hospital monitoring.
In C5 as in C3, the nephrologists performed kidney biopsy under tomodensitometry guidance. Two fragments were taken with a 16-gauge needle automatic biopsy gun as in C4. Blood cell count, coagulation tests, and bleeding time were performed before biopsy and blood pressure ^ 150/90 mm Hg was required. C5 was the only unit requiring urinalysis before biopsy. As in all the previous units, patients stayed in bed for 24 h in hospital.
No unit performed real-time check of the number of glomeruli through a contrast phase microscope to avoid RB failure.
Laboratory Biopsy Analysis
One fragment was taken for LM and the other for IF. For LM, tissue was fixed in 2.5% glutaraldehyde for 12 h and embedded in araldite. Serial sections of 2 and 0.25 m were stained respectively with Masson's trichrome and Jones' staining. Glomeruli were counted only if the whole glomerulus was present on the specimen. Material for IF was fixed in Michel's liquid for 24-48 h and then frozen in -80 ° C isopentane. Sections of 5 m were used for IF with fluorescein-conjugated antibodies specific for human IgG, IgM, IgA, C3, C1q, and and light chains. Glomeruli on frozen sections were counted excluding sclerosed glomeruli. During the study, all biopsies were read by the same pathologist. When no glomeruli were available, the biopsy was considered to have failed. In most glomerulopathy classifications, at least 10 glomeruli are required to consider the core biopsy representative and the diagnosis accurate [12] [13] [14] . Thus, on LM analysis, biopsies were separated into three groups according to the number of glomeruli on tissue fragments: 0 glomeruli, 1-9 glomeruli, and 6 10 glomeruli. On IF analysis, because the number of glomeruli is less critical, biopsies were separated into only two groups: those with glomeruli and those with no glomeruli.
Statistical Analysis
For univariate analysis, mean comparisons were tested using analysis of variance (or Kruskal-Wallis test if necessary). Relationships between qualitative variables were assessed using Pearson's 2 (or Fisher's exact test if necessary). Relationships between quantitative variables were assessed using Pearson's correlation coefficient (or Spearman's approach if necessary).
For multivariate analysis, because of co-linearity between the nephrology unit and RB technique elements in our retrospective study, we did a two-step analysis: the first step included age, gender, nephrology unit and renal histology, and the second step included elements of RB technique: radiological guidance, biopsy performer, needle gauge, but not nephrology unit. Logistic regression assessed covariates associated to LM and IF. p values were interpreted with a risk r = 0.05. PASW 17.0.2 (SPSS Inc.) software was used for statistical analysis.
Results
Data from 943 native kidney RB were collected (C1 408, C2 254, C3 81, C4 136, C5 64). Of these, 534 (57%) were men. The sex ratio was not different between the five nephrology units (p = 0.053). Mean age at biopsy was 52.8 8 19.7 (mean 8 SD) years ( table 2 ) . It was statistically higher in C2 (57.2 8 20.0 years) than in the other units (p ! 0.001).
Safety of Renal Biopsy Procedures
Serious adverse events occurred in 1.5% (14/943) of native kidney biopsies ( table 3 ) . No deaths or nephrectomies were reported. The complication rate was not statistically influenced by nephrology unit (p = 0.7), age (p = 0.3), or gender (p = 1).
Efficiency of Renal Biopsy Procedures
On LM, the mean number of glomeruli on biopsy core was 14.2 8 8.6 (mean 8 SD). It was statistically higher in C1 (15.1 8 9.1) and C2 (14.3 8 8.3) than in C3 (12.3 8 9.5), C4 (12.7 8 7.3), and C5 (13.3 8 7.4) (p = 0.01). The number of biopsies with at least 10 glomeruli on LM was 651/943 (69%). It was higher in C1 (72%) and C2 (71%) than in C3 (57%), C4 (63%), and C5 (67%) (p = 0.004) ( fig. 1 a) . On IF, the mean number of glomeruli on biopsy core was 4.4 8 3.3 (mean 8 SD). As for LM, the mean number of glomeruli was higher in C1 (5.2 8 3.8) and C2 (4.4 8 2.9) than in C3 (2.7 8 2.9), C4 (3.6 8 2.4), and C5 (3.6 8 2.7) (p ! 0.001) ( fig. 1 b) .
The number of failed biopsies was 48/943 (5%) on LM. This rate was higher in C1 (8%) and C3 (9%) than in the other units (p ! 0.001). The number of failed biopsies on IF was 99/943 (10%). It was higher in C3 (33%) than in the other nephrology units (p ! 0.001). Causes of failure are classified in two categories: medullary core with no glomeruli or no kidney core ( table 4 ) .
Renal diseases were nephroangiosclerosis (14%), IgA nephropathy (10%), minimal-change nephropathy (9%), extracapillary glomerulonephritis (9%), lupus nephropathy (9%), focal and segmental glomerular sclerosis (8%), membranous glomerulonephritis (8%), interstitial nephritis (6%), diabetic nephropathy (4%), amyloidosis (3%), membranoproliferative glomerulonephritis (2%), others (14%), and no diagnosis (4%). Histology influ- In multivariate analysis, the only factor that significantly influenced the number of glomeruli on LM (p = 0.004) and IF (p = 0.004) was the nephrology unit.
After assessing that the nephrology unit was the main factor influencing RB quality, we searched within the nephrology unit procedures which element was associated to RB efficiency: radiological guidance technique, corecutting needle size or biopsy performer. Failure of RB was influenced by radiological guidance technique (p ! 0.001 for LM and for IF) and biopsy performer (p ! 0.001 for LM and p = 0.011 for IF) but not needle size (p = 0.086 for LM and p = 0.6 for IF) (online suppl. tables S1 and S2; see www.karger.com/doi/10.1159/000337932 for all online suppl. material). Real-time US guidance had a failure rate of 2%, tomodensitometry guidance of 6% and US assessment before RB of 8% (online suppl. table S1). When RB was a success, the number of glomeruli on LM kidney core was influenced by needle size (p = 0.027) (online suppl. table S2) and by radiological guidance technique (5) 244 (26) 651 (69) 32 (8) 81 (20) 295 (72) 3 (1) 70 (28) 181 (71) 7 (9) 28 (34) 46 (57) 4 (3) 46 (34) 86 (63) 2 (3) 19 (30) (10) 37 (9) 16 (6) 27 (33) 13 (10) 6 (9) <0.001 Number of biopsies with serious adverse events 14 (1.5)
Figures are mean 8 SD or n (%). (p = 0.003). 70% of RB had 10 or more glomeruli using a 14-gauge core-cutting needle size and 64% using 16-gauge needles (online suppl. table S2). Biopsy performer did not influence the number of RB with 6 10 glomeruli (online suppl. table S3).
Discussion
Most nephrologists perform RB by a standard technique developed in the early 1990s with an automated biopsy device and radiological guidance [15] . Its superiority over previous techniques has been validated [11] . Many options remain possible for radiological guidance techniques, and core-cutting needle size may vary between 14-and 18-gauge. Moreover, the precautions taken before and after biopsy vary according to nephrology units [16] . In our retrospective study of 943 kidney biopsies comparing five different practices, we found no difference concerning severe complications according to biopsy procedure, but the choice of the procedure may affect biopsy efficiency.
The practices in our study are representative of practices in nephrology units in France [1] . Within the five Color version available online nephrology units, all gave oral and written information prior to biopsy concerning indication, technique, monitoring, and recommended post-procedure precautions or potential complications. Four out of five units obtained written consent for RB. Bollée et al. [1] reported 56% of units in France gave oral and written information and only 44% of units obtained written consent. Assessment of hemorrhagic risk factors before RB included oral questioning about personal history of bleeding, blood cell count, and coagulation tests (prothrombin time and activated partial prothrombin time) in all units, but none obtained written questioning about personal history of bleeding. Differences appeared regarding bleeding time, which was recorded in only two units, and in platelet function analyzer (PFA100), recorded in one unit. Two units reported neither bleeding time nor platelet function analyzer. In all of France, 100% of nephrologists perform coagulation tests, 98% blood cell count, 76% oral questioning about personal history of bleeding, 57% bleeding time, and 11% PFA100 [1] . Units C3 and C4 were stringent with hypertension, whereas C2 tolerated hypertension of 160/95. In the literature, it remains controversial whether hypertension increases hemorrhagic risk [3, 5, 17] . All of our patients were hospitalized for 24 h after biopsy. Whittier and Korbet [17] reported a 33% risk of bleeding occurring 8 h after biopsy and an 11% risk of bleeding more than 24 h after biopsy. When minimal precautions are taken (blood cell count, coagulation test, no uncontrolled hypertension), RB is safe whatever the procedure used. In our pragmatic study, we found an overall serious adverse event rate of 1.5%, which is consistent with previously reported rates [3, 16] . In the literature, serious complication following RB ranges from 0 to 7.7% [18] . This rate is higher using a Tru-Cut device instead of an automated biopsy gun [19, 20] . Tru-Cut is now abandoned for RB. In a retrospective study of 5,832 renal biopsies, Atwell et al. [21] reported an overall complication rate of 0.6%, which did not differ whether the patient was treated by aspirin or not at biopsy. In our study, no difference was found between nephrology units, even when no bleeding time was performed. Thus, RB complication remains rare and the technical procedure does not affect the rate of serious complications. Nevertheless, techniques might influence the efficiency of the kidney biopsy.
In our overall population, biopsy failed on LM and IF in respectively 5 and 10% of biopsies. Reported rates of failed biopsy range between 0 and 6% [2, 18, 22] . Scheckner et al. [23] reported a 10.7% rate of inconclusive renal biopsies, including 1.5% with no kidney core available in a pediatric population. In our study, the number of failed biopsies was higher in C1 and C3. We found that the main factor influencing the number of failed biopsies is the radiological guidance technique, real-time US guidance providing the smallest rate of failed biopsies (2%). C1 used US assessment before RB and C3 tomodensitometry guidance. In our study, radiological guidance was critical regarding the number of failed biopsies, US guidance being the best technique. Surprisingly, tomodensitometry guidance was less efficient than US guidance: the number of failed biopsies were respectively 6 versus 8% on LM and 23 versus 9% on IF (online suppl. table S1).
Failed biopsies in centers using US guidance were mainly due to medullary sampling, but failed biopsies of other radiological techniques were due to the absence of kidney core ( table 4 ) . Thus, failure of biopsies with US assessment before RB and tomodensitometry guidance is certainly due to imprecise kidney localization. This finding is supported by the findings of Maya et al. [11] , who showed that US guidance was more efficient than US previous assessment before RB.
The number of glomeruli is critical for interpretation and classification of nephropathy in numerous international classifications. At least 10 glomeruli are recommended to provide an accurate diagnosis and prognosis based on RB [12] [13] [14] . According to the literature, mean numbers of glomeruli on biopsies vary between 9 and 33 [18] according to needle size [19, 20] . In C1 and C2, the mean number of glomeruli and the proportion of kidney biopsies with more than 10 glomeruli were higher than in the other units. Two explanations can be given. First, C1 and C2 used 14-gauge core-cutting needles. In the literature, the size of the needle influences the mean number of glomeruli on biopsies [8] , and logically, 14-gauge needles provide more glomeruli on biopsy. We also found in our study a link between core-cutting needle size and the number of glomeruli on kidney core favoring 14-gauge. Interestingly, C1 had a high mean number of biopsies with 10 or more glomeruli but also a high rate of failed biopsies. This unit used 14-gauge needles, but US assessment before RB. The rate of biopsies with more than 10 glomeruli was higher in units performing the more biopsies (662 for C1/C2 vs. 281 for C3/C4/C5). Clearly, biopsy experience of unit is important for efficiency.
Limitations of this study are retrospective data recording, lack of report of minor (but infrequently clinically relevant) complications, and absence of 1-day procedure comparison. However, for native kidney, full hospitalization is the main procedure in France and worldwide [1] . The 24-hour follow-up after the procedure is important regarding the 20% rate of complications occurring between the 8th and the 24th hour following RB [17] .
In conclusion, RB is safe, with an overall serious adverse event rate of 1.5% regardless of the procedure used. The quality of biopsies is influenced by radiological guidance and core-cutting needle size. Real-time US guidance and a 14-gauge core-cutting needle automatic biopsy device could be considered as the gold standard for native kidney biopsy.
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